Replay available

Oscar Health, Inc. (OSCR) Q1 2026 Earnings Call

Oscar Health, Inc. (NYSE: OSCR) Q1 2026 earnings conference call, held 2026-05-06. Replay captured from the company's public earnings webcast.

Wed, May 6, 2026 at 8:00 AMendedReplay
Oscar Health, Inc. (OSCR) Q1 2026 Earnings Call

Investor webinar replay

Latest news releases

Companies on this event

Featured Presenters

Chris Potichar

Vice President of Treasury and Investor Relations

Mark Bertolini

Chief Executive Officer

Scott Blackley

Chief Financial Officer

Jessica Tassan

Analyst

John Ransom

Analyst

Andrew Monk

Analyst

Jonathan Young

Analyst

Olivia Miles

Analyst (for Michael Ha)

Raj Kumar

Analyst

Craig Jones

Analyst

Replay transcript excerpt

Good morning. My name is Jeannie and I will be your conference operator today. At this time, I would like to welcome everyone to Oscar Health's first quarter 2026 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, Press star 1 again. Today, we ask you to limit to one question and one follow-up. Thank you. I will now turn the conference over to Chris Potichar, Vice President of Treasury and Investor Relations. Good morning, everyone. Thank you for joining us for our first quarter 2026 earnings call. Mark Bertolini, Oscar Hell's Chief Executive Officer, and Scott Blackley, Oscar Hell's Chief Financial Officer, will host this morning's call. This call can also be accessed through our investor relations website at ir.highoscar.com. Full details of our results and additional management commentary are available in our earnings release, which can be found on our investor relations website at ir.highoscar.com. Any remarks that Oscar makes about the future constitute forward-looking statements within the meaning of safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements as a result of various important factors, including those discussed in our annual report on Form 10-K for the period ended December 31, 2025, filed with the Securities and Exchange Commission, and other filings with the SEC, including our quarterly report on Form 10-Q for the period ended March 31, 2026, to be...

More from Oscar Health, Inc.